You are here

vonoprazan

Takeda gives Sun Pharma, Cipla rights to commercialize gastro drug in India

Reuters

Fri, 06/21/24 - 11:02 am

FDA decision, launch of gastrointestinal drug delayed after nitrosamine found in commercial batches

Endpoints

Wed, 01/4/23 - 10:03 am

Phathom Pharmaceuticals

erosive esophagitis

Takeda veterans, Frazier launch Phathom with $90M to develop GI drug vonoprazan

BioCentury

Wed, 05/15/19 - 11:42 pm

Frazier Healthcare

gastrointestinal